G12A (p.Gly12Ala) variant of KRAS (GTPase KRas)

G12A (p.Gly12Ala) in KRAS (GTPase KRas) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic/likely pathogenic in the context of KRAS-related disorder; Gastric cancer; Familial cancer of breast. The available variant effect predictions contribute to a CATVariant prioritization score of 0.77 / 1. The record also includes population frequency data, experimental measurements, published literature, and structural context.

G12A (p.Gly12Ala) variant details